210 related articles for article (PubMed ID: 34004255)
1. hTERT-molecular targeted therapy of ovarian cancer cells via folate-functionalized PLGA nanoparticles co-loaded with MNPs/siRNA/wortmannin.
Ghareghomi S; Ahmadian S; Zarghami N; Hemmati S
Life Sci; 2021 Jul; 277():119621. PubMed ID: 34004255
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of human telomerase reverse transcriptase induces apoptosis in cervical cancer cell line.
Nagapoosanam AL; Ganesan N; Umapathy D; Moorthy RK; Arockiam AJV
Indian J Med Res; 2019 Mar; 149(3):345-353. PubMed ID: 31249199
[TBL] [Abstract][Full Text] [Related]
3. Anti-tumor efficacy of folate modified PLGA-based nanoparticles for the co-delivery of drugs in ovarian cancer.
Li S; Li X; Ding J; Han L; Guo X
Drug Des Devel Ther; 2019; 13():1271-1280. PubMed ID: 31114163
[No Abstract] [Full Text] [Related]
4. Enhanced antitumor efficacy in colon cancer using EGF functionalized PLGA nanoparticles loaded with 5-Fluorouracil and perfluorocarbon.
Wu P; Zhou Q; Zhu H; Zhuang Y; Bao J
BMC Cancer; 2020 Apr; 20(1):354. PubMed ID: 32345258
[TBL] [Abstract][Full Text] [Related]
5. The Effects of Nanoencapsulated Curcumin-Fe3O4 on Proliferation and hTERT Gene Expression in Lung Cancer Cells.
Sadeghzadeh H; Pilehvar-Soltanahmadi Y; Akbarzadeh A; Dariushnejad H; Sanjarian F; Zarghami N
Anticancer Agents Med Chem; 2017; 17(10):1363-1373. PubMed ID: 28270067
[TBL] [Abstract][Full Text] [Related]
6. CD44-Targeting PLGA Nanoparticles Incorporating Paclitaxel and FAK siRNA Overcome Chemoresistance in Epithelial Ovarian Cancer.
Byeon Y; Lee JW; Choi WS; Won JE; Kim GH; Kim MG; Wi TI; Lee JM; Kang TH; Jung ID; Cho YJ; Ahn HJ; Shin BC; Lee YJ; Sood AK; Han HD; Park YM
Cancer Res; 2018 Nov; 78(21):6247-6256. PubMed ID: 30115698
[TBL] [Abstract][Full Text] [Related]
7. Nanoparticle co-delivery of wortmannin and cisplatin synergistically enhances chemoradiotherapy and reverses platinum resistance in ovarian cancer models.
Zhang M; Hagan CT; Min Y; Foley H; Tian X; Yang F; Mi Y; Au KM; Medik Y; Roche K; Wagner K; Rodgers Z; Wang AZ
Biomaterials; 2018 Jul; 169():1-10. PubMed ID: 29631163
[TBL] [Abstract][Full Text] [Related]
8. A multifunctional-targeted nanoagent for dual-mode image-guided therapeutic effects on ovarian cancer cells.
Chen C; Sun J; Chen S; Liu Y; Zhu S; Wang Z; Chang S
Int J Nanomedicine; 2019; 14():753-769. PubMed ID: 30718954
[TBL] [Abstract][Full Text] [Related]
9. Development of L-carnosine functionalized iron oxide nanoparticles loaded with dexamethasone for simultaneous therapeutic potential of blood brain barrier crossing and ischemic stroke treatment.
Lu X; Zhang Y; Wang L; Li G; Gao J; Wang Y
Drug Deliv; 2021 Dec; 28(1):380-389. PubMed ID: 33586561
[TBL] [Abstract][Full Text] [Related]
10. Specific cellular internalization and pH-responsive behavior of doxorubicin loaded PLGA-PEG nanoparticles targeted with anti EGFRvIII antibody.
Eivazi N; Rahmani R; Paknejad M
Life Sci; 2020 Nov; 261():118361. PubMed ID: 32861796
[TBL] [Abstract][Full Text] [Related]
11. Luminescent/magnetic PLGA-based hybrid nanocomposites: a smart nanocarrier system for targeted codelivery and dual-modality imaging in cancer theranostics.
Shen X; Li T; Chen Z; Geng Y; Xie X; Li S; Yang H; Wu C; Liu Y
Int J Nanomedicine; 2017; 12():4299-4322. PubMed ID: 28652734
[TBL] [Abstract][Full Text] [Related]
12. In vitro evaluation of folate-modified PLGA nanoparticles containing paclitaxel for ovarian cancer therapy.
Luiz MT; Abriata JP; Raspantini GL; Tofani LB; Fumagalli F; de Melo SMG; Emery FDS; Swiech K; Marcato PD; Lee R; Marchetti JM
Mater Sci Eng C Mater Biol Appl; 2019 Dec; 105():110038. PubMed ID: 31546359
[TBL] [Abstract][Full Text] [Related]
13. Enhanced cancer therapy with pH-dependent and aptamer functionalized doxorubicin loaded polymeric (poly D, L-lactic-co-glycolic acid) nanoparticles.
Saravanakumar K; Hu X; Shanmugam S; Chelliah R; Sekar P; Oh DH; Vijayakumar S; Kathiresan K; Wang MH
Arch Biochem Biophys; 2019 Aug; 671():143-151. PubMed ID: 31283911
[TBL] [Abstract][Full Text] [Related]
14. Dual CD44 and folate receptor-targeted nanoparticles for cancer diagnosis and anticancer drug delivery.
Lee JY; Termsarasab U; Park JH; Lee SY; Ko SH; Shim JS; Chung SJ; Cho HJ; Kim DD
J Control Release; 2016 Aug; 236():38-46. PubMed ID: 27320169
[TBL] [Abstract][Full Text] [Related]
15. Gene silencing effect of SiRNA-magnetic modified with biodegradable copolymer nanoparticles on hTERT gene expression in lung cancer cell line.
Fekri Aval S; Akbarzadeh A; Yamchi MR; Zarghami F; Nejati-Koshki K; Zarghami N
Artif Cells Nanomed Biotechnol; 2016; 44(1):188-93. PubMed ID: 25020049
[TBL] [Abstract][Full Text] [Related]
16. Potentiation of Folate-Functionalized PLGA-PEG nanoparticles loaded with metformin for the treatment of breast Cancer: possible clinical application.
Jafari-Gharabaghlou D; Dadashpour M; Khanghah OJ; Salmani-Javan E; Zarghami N
Mol Biol Rep; 2023 Apr; 50(4):3023-3033. PubMed ID: 36662452
[TBL] [Abstract][Full Text] [Related]
17. AS1411 aptamer-decorated cisplatin-loaded poly(lactic-co-glycolic acid) nanoparticles for targeted therapy of miR-21-inhibited ovarian cancer cells.
Vandghanooni S; Eskandani M; Barar J; Omidi Y
Nanomedicine (Lond); 2018 Nov; 13(21):2729-2758. PubMed ID: 30394201
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of targeted curcumin (CUR) loaded PLGA nanoparticles for in vitro photodynamic therapy on human glioblastoma cell line.
Jamali Z; Khoobi M; Hejazi SM; Eivazi N; Abdolahpour S; Imanparast F; Moradi-Sardareh H; Paknejad M
Photodiagnosis Photodyn Ther; 2018 Sep; 23():190-201. PubMed ID: 29969678
[TBL] [Abstract][Full Text] [Related]
19. Folate receptor-targeted PLGA-PEG nanoparticles for enhancing the activity of genistein in ovarian cancer.
Patra A; Satpathy S; Naik PK; Kazi M; Hussain MD
Artif Cells Nanomed Biotechnol; 2022 Dec; 50(1):228-239. PubMed ID: 36330543
[TBL] [Abstract][Full Text] [Related]
20. Folate-modified PLGA nanoparticles for tumor-targeted delivery of pheophorbide a in vivo.
Son J; Yang SM; Yi G; Roh YJ; Park H; Park JM; Choi MG; Koo H
Biochem Biophys Res Commun; 2018 Apr; 498(3):523-528. PubMed ID: 29518390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
